What are Supernus Pharmaceuticals's profit margins?

Gross margin is 89.4% and operating margin is -7.8%, with a -3.7% net margin.

Where does Supernus Pharmaceuticals's income statement data come from?

Every line is extracted from Supernus Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Supernus Pharmaceuticals SUPN Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Total revenue	$776.83M+8.1%	$718.95M+5.5%	$681.54M+2.5%	$665.13M-0.4%	$668M+0.9%
Total cost of revenue	$82.19M+10.2%	$74.56M-4.0%	$77.65M+1.8%	$76.27M-1.4%	$77.36M-0.7%
Gross profit	$694.64M+7.8%	$644.39M+6.7%	$603.89M+2.6%	$588.85M-0.3%	$590.64M+1.2%
Gross margin	89.4%-0.2pp	89.6%+1.0pp	88.6%+0.1pp	88.5%+0.1pp	88.4%+0.2pp
Research and development	$118.75M+11.8%	$106.24M-0.8%	$107.06M+0.3%	$106.73M-3.7%	$110.79M+1.8%
Selling, general and administrative	$520.79M+7.3%	$485.56M+9.7%	$442.58M+33.0%	$332.66M+2.4%	$325.01M+1.1%
Total costs & expenses	$837.19M+7.2%	$781.24M+8.7%	$718.48M+19.5%	$600.99M+1.3%	$593.43M+2.3%
Operating income	-$60.36M+3.1%	-$62.28M-68.6%	-$36.94M-158%	$64.14M-14.0%	$74.56M-8.7%
Operating margin	-7.8%+0.9pp	-8.7%-3.2pp	-5.4%-15.1pp	9.6%-1.5pp	11.2%-1.2pp
Other income (expense), net	$11.21M-15.4%	$13.25M-18.2%	$16.21M-10.1%	$18.03M+4.6%	$17.23M+6.4%
Income before income taxes	-$49.15M-0.2%	-$49.03M-136%	-$20.73M-125%	$82.16M-10.5%	$91.8M-6.2%
Income tax expense	——	——	-$1.62M-109%	$17.67M-40.9%	$29.88M+24.5%
Net income	-$29.02M+24.7%	-$38.55M-102%	-$19.12M-130%	$64.5M+4.2%	$61.91M-16.2%
Net margin	-3.7%+1.6pp	-5.4%-2.6pp	-2.8%-12.5pp	9.7%+0.4pp	9.3%-1.9pp
Diluted earnings per share	-$0.51+25.0%	-$0.68-100%	-$0.34-130%	$1.15+3.6%	$1.11-15.9%
EBITDA	$36.95M+26.2%	$29.28M-39.6%	$48.45M-66.5%	$144.82M-6.3%	$154.61M-4.6%
EBITDA margin	4.8%+0.7pp	4.1%-3.0pp	7.1%-14.7pp	21.8%-1.4pp	23.1%-1.3pp
EBIT	-$60.36M+3.1%	-$62.28M-68.6%	-$36.94M-158%	$64.14M-14.0%	$74.56M-8.7%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Supernus Pharmaceuticals's profit margins?: Gross margin is 89.4% and operating margin is -7.8%, with a -3.7% net margin.
Where does Supernus Pharmaceuticals's income statement data come from?: Every line is extracted from Supernus Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.